Circulating microRNAs as a Fingerprint for Liver Cirrhosis
Yanjie Chen(Chongqing Medical University), Xizhong Shen(Shanghai Medical College of Fudan University), Xiaoling Guo(Hebei Medical University), Jie Hu(Zhongshan Hospital), Jian Zhou(Shenzhen University Health Science Center), Hao Wu(Stanford Medicine), Ji‐Min Zhu(Fudan University), Jia Fan(Nanjing Tech University), Taotao Liu(Sun Yat-sen University), Qian Yu(Fudan University), Xiaowu Huang(Sun Yat-sen University), Lei Yang(Fudan University), Chunlei Wu(Scripps Research Institute)
Cited by 69
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828